For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Nasdaq, Inc. (NDAQ) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-25): Designation Watch · Gem Score -14 (−100…+100 Quality+Value blend) · Quality 51 · Value -67 · Sentiment 24 (timing only, not weighted) · Composite fair value $67.16 vs $97.02 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Nasdaq, Inc.
NDAQ NASDAQNasdaq, Inc. is a global financial technology and services company headquartered in New York City, United States. It provides data, analytics, software, and exchange capabilities to corporate issuers, asset managers, banks, brokers, and other market participants across the global financial system. Nasdaq, Inc. operates a portfolio of regulated markets in the U.S. and Europe and delivers trading, clearing, and market access solutions across multiple asset classes. The company’s activities are organized into key business segments including Capital Access Platforms, Financial Technology, and Market Services, reflecting its role in listings, market data, index licensing, and market infrastructure. In addition to running stock and derivatives markets, Nasdaq, Inc. offers anti-financial-crime technology, surveillance and regulatory software, and corporate workflow and investor relations tools that support capital-raising and compliance processes. Through these platforms and services, Nasdaq, Inc. plays a central role in enhancing transparency, integrity, and efficiency in global capital markets.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 3.09
Total Equity: $12.23B
Shares: 578,640,777
Total Debt: $9.00B
Cash: $604.00M
EBITDA: $3.15B
Total Debt: $9.00B
Cash: $604.00M
Revenue: $8.26B
Revenue: $8.26B
Revenue: $8.26B
Total Equity: $12.23B
Tax Rate: 16.7%
Equity: $12.23B
Total Debt: $9.00B
Cash: $604.00M
Current Liabilities: $7.96B
Long-Term Debt: $8.57B
Total Debt: $9.00B
Total Equity: $12.23B
Shares: 578,640,777
Shares: 578,640,777
CapEx: -$266.00M
Shares: 578,640,777
Stock Price: $97.02
Net Income: $1.79B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 11, 2026 12:54pm (14d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $5.9B | $6.2B | $6.1B | $7.4B | $8.3B |
| Cost of Revenue | $3.7B | $3.9B | $3.5B | $4.4B | $4.8B |
| Gross Profit | $2.2B | $2.3B | $2.5B | $3.0B | $3.5B |
| Operating Expenses | $673.0M | $678.0M | $740.0M | $1.0B | $1.1B |
| Operating Income | $1.6B | $1.7B | $1.8B | $1.9B | $2.4B |
| Net Income | $1.2B | $1.1B | $1.1B | $1.1B | $1.8B |
| EBITDA | $2.0B | $2.0B | $2.2B | $2.6B | $3.1B |
| EPS | $2.38 | $2.28 | $2.10 | $1.94 | $3.12 |
| EPS (Diluted) | $2.35 | $2.26 | $2.08 | $1.93 | $3.09 |
Balance Sheet (Annual)
Last updated: Aug 16, 2026 12:09am (9d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $393.0M | $502.0M | $453.0M | $592.0M | $604.0M |
| Total Current Assets | $7.4B | $8.6B | $9.1B | $7.8B | $8.0B |
| Total Assets | $20.1B | $20.9B | $32.3B | $30.4B | $31.1B |
| Current Liabilities | $7.9B | $8.8B | $9.0B | $7.9B | $8.0B |
| Long-Term Debt | $4.8B | $4.7B | $10.2B | $9.1B | $8.6B |
| Total Liabilities | $13.7B | $14.7B | $21.5B | $19.2B | $18.8B |
| Total Equity | $6.4B | $6.2B | $10.8B | $11.2B | $12.2B |
| Retained Earnings | $6.5B | $7.2B | $7.8B | $8.4B | $9.6B |
Cash Flow (Annual)
Last updated: Aug 16, 2026 12:27am (9d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.7B | $1.7B | $1.9B | $2.3B |
| Capital Expenditure | -$163.0M | -$152.0M | -$158.0M | -$207.0M | -$266.0M |
| Free Cash Flow | $920.0M | $1.6B | $1.5B | $1.7B | $2.0B |
| Acquisitions (net) | -$2.4B | -$41.0M | -$5.8B | $0 | $0 |
| Net Debt Issued / (Repaid) | $4.1B | $3.1B | -$260.0M | $476.0M | -$826.0M |
| Dividends Paid | -$350.0M | -$383.0M | -$441.0M | -$541.0M | -$601.0M |
| Stock Buybacks | -$468.0M | -$308.0M | -$269.0M | -$145.0M | -$616.0M |
| Net Change in Cash | -$483.0M | $1.5B | $124.0M | -$2.1B | -$1.1B |
Growth Trends (YoY %)
Last updated: Aug 11, 2026 12:54pm (14d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +5.8% | -2.6% | +22.0% | +11.6% |
| Gross Profit Growth | +4.8% | +8.8% | +17.4% | +16.7% |
| Operating Income Growth | +6.5% | +8.7% | +7.9% | +24.8% |
| Net Income Growth | -5.2% | -5.9% | +5.5% | +60.1% |
| EBITDA Growth | -0.6% | +14.1% | +17.4% | +20.5% |
Dividend History (Last 20)
Last updated: Aug 11, 2026 12:54pm (14d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-09-11 | $0.31 | — | — | — |
| 2026-06-12 | $0.31 | — | — | — |
| 2026-03-16 | $0.27 | — | — | — |
| 2025-12-05 | $0.27 | — | — | — |
| 2025-09-12 | $0.27 | — | — | — |
| 2025-06-13 | $0.27 | — | — | — |
| 2025-03-14 | $0.24 | — | — | — |
| 2024-12-06 | $0.24 | — | — | — |
| 2024-09-13 | $0.24 | — | — | — |
| 2024-06-14 | $0.24 | — | — | — |
| 2024-03-13 | $0.22 | — | — | — |
| 2023-12-07 | $0.22 | — | — | — |
| 2023-09-14 | $0.22 | — | — | — |
| 2023-06-15 | $0.22 | — | — | — |
| 2023-03-16 | $0.20 | — | — | — |
| 2022-12-01 | $0.20 | — | — | — |
| 2022-09-15 | $0.20 | — | — | — |
| 2022-06-09 | $0.20 | — | — | — |
| 2022-03-10 | $0.18 | — | — | — |
| 2021-12-02 | $0.18 | — | — | — |
Deep Analysis
Risk : Reward — if the last quarter repeats
Live · as of 2026-08-23 02:58Even the bull case prices 8% below today — the ratio here measures the model-vs-market gap, not payoff odds. Another quarter like the worst recent one costs 63%. Caveat: revenue-DCF fits financials poorly (reported revenue omits net interest) — treat the legs as rough.
| Case | Growth | Margin | Fair value | vs price ($97.02) |
|---|---|---|---|---|
| Bull — recovery | +24% | 31.8% | $89.30 | -8% |
| Base — stabilizes | +16% | 27.7% | $61.80 | -36% |
| Bear — keeps slipping | +8% | 23.5% | $41.62 | -57% |
| Stress — last quarter repeats | +2% | 24.8% | $35.83 | -63% |
Narrative Economics
market-narrative step).
AI Lens 4th lens · how AI reaches this business · 5-yr
2026-08-16AI-driven trading and agentic analytics increase order flow, message volume, connectivity and demand for licensed proprietary order-book data — Nasdaq's transaction, colocation and data units scale with machine activity, not headcount. Simultaneously AI compresses the cost of building and servicing AxiomSL/Calypso/Verafin deliverables while regulatory willingness-to-pay is unchanged.
A meaningful slice of market data revenue is priced per professional user/display. If analyst, trader and sales headcount at banks and asset managers falls as agents do the reading, subscriber counts shrink even as raw data consumption rises — and regulators already resist repricing that gap away.
Whether Nasdaq successfully migrates data monetization from per-human-subscriber to enterprise/API/consumption licensing at equal or better economics. Observable: professional subscriber counts versus data revenue per client, and disclosed enterprise-license mix in Capital Access Platforms.
SEC/EU-regulated market operator status, the liquidity network effect and proprietary tape, exchange-grade surveillance and clearing certifications, and Verafin's cross-institution financial-crime consortium data — none of which cheap code confers.
AI Lens thesis
Nasdaq is three different AI stories stapled together. The exchange itself is near-insulated in the ABNB sense: matching, clearing and regulated listing status are licence-and-network assets, and more machine intelligence in the market means more messages, more colocation, more data licences — AI arrives as volume, not substitution. The Financial Technology segment is a PAYC-type shield: AxiomSL regulatory reporting and Calypso risk/treasury workflows are legally exhaustive and liability-bearing, so even a technically capable internal LLM build is unattractive because no bank wants to own the regulatory-filing blame; meanwhile AI cuts Nasdaq's own implementation and support cost, the most labour-heavy part of that P&L. Verafin is the genuinely AI-accelerated asset — consortium fraud data across thousands of institutions makes its models better than any single bank's, and AI-enabled fraud and deepfake payment scams expand the addressable problem it is hired to absorb. The exposure that actually matters is the monetized unit in market data and index/analytics: per-user, per-display and per-seat pricing is levered to shrinking human seat counts in finance, and regulatory scrutiny of data fees limits Nasdaq's ability to reprice. Net: the scarce assets get scarcer, the cost base gets cheaper, and the risk is unit-of-charge migration rather than displacement.
What the market may be underestimating
Upside Licensing full-depth historical and real-time exchange data for model training and agent execution is a new, high-margin unit priced to machines rather than to humans — and Nasdaq controls a dataset that cannot be synthesized.
Downside Calypso and parts of the analytics stack are configurable enterprise software where AI collapses implementation cost — the differentiator there is integration labour, exactly what cheap coding erodes, so ARR quality inside FinTech may be more mixed than the segment's headline growth suggests.
Outcome range spread 42
Growth Outlook
Analyzed 2026-08-17 16:33The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
Looking at the raw quarterly print first: Q2 2026 revenue of $2.53B is a genuine step-function jump from a stable ~$2.10B run-rate that held for four straight quarters (Q1 2025 through Q1 2026). That's an 18% sequential jump — either a real acceleration (Adenza cross-sell hitting, Financial Technology division scaling) or a one-off (acquisition close, calendar quirk, market volatility spike). Net income actually dropped to $507M on higher revenue, so the 20% margin is 430bps below the prior quarter's 24.3% — the incremental revenue came in at low/negative marginal margin. That is a red flag the synthesis buries. Either mix shifted toward lower-margin tech services (bullish long-term, dilutive near-term) or there's integration/one-time drag. Either way, the "60% earnings YoY" figure the momentum model cites is flattered by a soft 2024 comp (Q2 2024 NI ~$300M range) and doesn't reflect the sequential margin compression happening right now.
On valuation, the synthesis DCF-anchored $66 fair value looks defensible but probably too harsh. Trailing FCF is $1.99B; on $54B market cap that's a 3.7% FCF yield, and with FCF growing at the 13.7% CAGR cited, an owner-earnings framework gets you closer to $75-80, not $66. However, 31x PE against CME at ~20x and ICE at ~24x is a real premium that requires the FinTech/Adenza thesis to compound at MSCI-like rates (12%+) for years — and the bear thesis is right that the index business faces entrenched competition and trading revenue is structurally soft. ROIC of 9.8% against a cost of capital probably in the 8-9% range means Nasdaq is barely creating economic value on incremental capital post-Adenza; the $9B debt load (0.74 D/E, current ratio 1.005 — thin) constrains further M&A optionality. This is not a business that deserves a growth multiple; it deserves a quality-utility multiple, which is closer to 22-25x, implying $75-85.
The insider signal is being misread by the "Net Insider Buying" tag. Two P-Purchase entries of 56,782 shares on June 11, 2026 look like a single transaction double-counted or a Form 4 filing artifact — and they're swamped by six S-Sales in July/August 2026 totaling ~46,000 shares at what were presumably higher prices. The pattern is insiders distributing after a run, not accumulating. The thesis evaluation score of -10 (nearly balanced bull/bear) is more honest than the synthesis's confident "overvalued -32%" call. I partially agree with the synthesis direction but think the magnitude is overstated — fair value is $75-82, not $66, making current $97 roughly 15-25% overvalued, not 32%.
The contrarian argument worth taking seriously: if Q2 2026's revenue jump is the start of a new plateau (not a blip), and the margin compression is Adenza integration noise that reverses in 2-3 quarters, then run-rate revenue of $10B+ with normalized 24% margins gets you to $2.4B in earnings, and 25x that is $60B market cap — basically here. So the bull needs the Q3 print to confirm ~$2.5B revenue with margins rebuilding toward 22-24%. If Q3 comes in at $2.2B and margins stay at 20%, the -32% synthesis view wins fast. I'd wait for the Q3 print before shorting, and I would not chase at $97. The stock is priced for the bull case to be right on both revenue durability AND margin recovery — an AND condition the market is treating as a near-certainty. That asymmetry favors the skeptic, but not with table-pounding conviction given the quality of the underlying franchise.
GPT Reading
Nasdaq’s raw numbers are better than the stock’s skeptical models give credit for, but not better enough to justify paying nearly $100. The business has clearly stepped up a level: annual revenue went from $6.06B in 2023 to $7.40B in 2024 and $8.26B in 2025, while operating income rose from $1.81B to $1.95B to $2.43B. That is not a stagnant exchange utility. The quarterly run-rate now sits above $9B annualized, with 2026 Q2 revenue at $2.53B, up from $2.10B a year earlier, and net income of $507M versus $452M. Even more important, margin progression is real: annual net margin improved from 17.5% in 2024 to 21.6% in 2025, and quarterly net margins have held mostly in the low-to-mid 20s since late 2025 versus mid-teens in late 2024. Free cash flow of $1.99B on $8.26B of revenue is a strong 24% conversion profile for a company with only $266M of capex. This is a very high-quality cash compounder with tangible operating leverage.
What stands out to me is that the market is treating that quality as if it has become a durable double-digit organic growth platform, and the reported numbers alone do not prove that yet. At $54.2B market cap, investors are paying about 27x 2025 free cash flow, 31x earnings, 6.8x sales, and over 20x EBITDA for a company whose core economics are excellent but whose returns on capital are not “software monopoly” caliber: ROIC is 9.8% and ROE 14.6%. Those are good, not elite. The balance sheet also matters more than bulls admit. Debt is $9.0B against just $604M of cash, so net debt is roughly $8.4B; enterprise value is therefore meaningfully higher than the equity quote suggests. For a business producing about $2.26B of operating cash flow, that leverage is manageable, but it limits the room for valuation fantasy. When a mature financial infrastructure name trades near 7.7x EV/revenue and 20.3x EV/EBITDA, I want to see either clearer evidence of sustainably faster growth or higher returns than this.
The strongest fact pattern in the stock is not that Nasdaq is weak; it is that it has genuinely improved. The jump in net income from $1.12B in 2024 to $1.79B in 2025 is enormous, and first-half 2026 net income of $1.03B implies another year that should land above $2.0B if trends hold. Recent quarterly revenue growth of about 12% and earnings growth of 60% are exactly the sort of numbers that make a premium multiple look rational at first glance. There is also some support from insider activity: amid several routine sales, there were two sizable June purchases totaling 113,564 shares, which is more interesting than the machine-readable “net insider buying” label alone. If the company is indeed shifting mix toward more recurring, less cyclical, higher-value data and workflow revenue, today’s multiples may be less outrageous than they look against legacy exchange comps.
But I still come back to price versus what is actually in hand. The annual history from 2021 to 2025 is solid, yet not linear enough to justify assuming a straight-line rerating into a premium information-services multiple. Revenue was $6.23B in 2022, then dipped to $6.06B in 2023 before reaccelerating, and net income was $1.19B in 2021, $1.13B in 2022, $1.06B in 2023, then surged. That pattern tells me part of the recent improvement is cyclical and integration-related rather than cleanly structural. The latest quarter also hints at some lumpiness: Q2 2026 revenue jumped to $2.53B, but net income of $507M was slightly below Q1’s $519M despite much higher sales, with margin dropping from 24.3% to 20.0%. That does not break the thesis, but it does argue against giving the company a frictionless “high-quality compounding SaaS” valuation. For me, fair value is closer to the low-to-mid $80s, where 2025 earnings and cash flow would still command a healthy premium for resilience and moat without assuming near-perfect execution.
What would change my mind is simple. If the next two quarters show revenue sustaining above $2.4B with net margin consistently above 24%, and if annualized free cash flow moves through $2.3B while debt trends down meaningfully from $9.0B, I would accept that the business deserves a premium closer to the current price or even above $100. On the other side, if growth falls back toward mid-single digits, margins slip back near 20%, or integration/leverage starts crowding out cash returns, the market will struggle to defend more than roughly 24-26x earnings, which points much closer to the modelled downside than bulls want to admit.
Grok Reading
The numbers describe a real operational step-change, not a narrative mirage. Annual revenue climbed from $6.06B in 2023 to $7.40B in 2024 and $8.26B in 2025, with net income leaping from $1.12B to $1.79B as net margin expanded from the mid-teens into the low-to-mid twenties. Free cash flow of $1.99B on only $266M of capex confirms the cash-conversion quality of the franchise. The latest quarter, however, is the tell: revenue spiked to $2.53B from a run-rate near $2.1B, yet the net margin compressed to 20% from 24% the prior two quarters. That mix or cost absorption is exactly what you would expect if Adenza-driven tech revenue is scaling while integration and go-to-market spend are still elevated. At $97 and 31.4x trailing earnings, 6.8x sales, and 20.3x EV/EBITDA, the market is capitalizing the company as if the higher-margin technology mix is already durable and the 30% earnings CAGR can be extrapolated. A 3.7% FCF yield and ROIC of 9.8% do not support that multiple for a still-levered balance sheet carrying $9.0B of debt against $604M of cash.
The quantitative models’ ~$66 fair-value anchor is directionally right even if the precise DCF is debatable. Peer exchange operators trade closer to the low-to-mid 20s on earnings; Nasdaq’s premium is almost entirely the optionality premium on data, index, and financial-crime software becoming a majority of economics. Recent revenue growth of roughly 12% year-over-year and a longer 16.7% revenue CAGR are solid, but they are not SaaS-compounder growth once you strip the volatility and M&A contribution. Net margin at 21–24% is already healthy for the category; further expansion is possible but not infinite under regulatory scrutiny of market-data pricing and index competition from MSCI and S&P. The stock is therefore pricing flawless execution of the “exchange-to-tech-platform” story at a level that leaves little room for a normal mid-cycle slowdown.
The strongest counter-case is straightforward and quantitative. Earnings CAGR near 30%, accelerating quarterly revenue, and high-confidence FCF quality argue the multiple can compress through growth rather than through a price decline. Large open-market purchases totaling over 113k shares in June 2026 sit against a string of smaller sales and undercut a pure insider-distribution read. If the technology and solutions segments continue to outgrow the transaction businesses and push group operating margin sustainably above 30% while organic growth holds in the low double digits, a mid-20s to low-30s earnings multiple becomes defensible rather than heroic. The platform-moat narrative is not fiction: listings, surveillance, and certain data feeds retain pricing power that pure software peers lack. A bull who believes Adenza monetization and AI/compliance upsell can deliver another leg of 15%+ growth for three-plus years can justify holding near $97; the data simply do not yet prove that trajectory is locked in.
I would reverse to neutral or constructive on a clean print of sequential margin re-expansion above 24% net alongside organic revenue growth still above 10% for two consecutive quarters, or on clear disclosure that recurring software and data already exceed half of revenue at peer-or-better retention. A sustained break of peer relative multiples without earnings disappointment, or net leverage falling meaningfully below 3x EBITDA while FCF stays near $2B, would also force a re-rating of the risk/reward. Until then the asymmetry favors the downside toward the mid-60s to mid-70s fundamental zone.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Revenue has compounded from $5.89B in 2021 to $8.26B in 2025 (about 8.8% CAGR), with operating margins holding in a 26-30% band and 2025 landing at 29.4% - the high end of the range. Net income jumped to $1.79B in 2025 from roughly $1.06-1.19B in the prior four years, and FCF has stepped up every year to $1.99B, with OCF/NI at 1.41x and accruals at -1.7% of assets - all consistent with high earnings quality (Beneish M -2.53 confirms). This is the profile of a mature, moaty financial-data and exchange franchise generating real cash.
Verify before trusting this (6)
- Debt maturity ladder and covenants post-Adenza; pace of deleveraging
- Organic vs acquired revenue growth split in 2024-2025 (how much of the step-up is Adenza)
- Segment mix: recurring/SaaS revenue share vs transaction/listings
- Customer concentration in Financial Technology / Adenza segment
- Buyback cadence vs SBC to confirm dilution is contained going forward
- Any goodwill/intangible balances and impairment risk from Adenza
Price is $97.02 against a composite fair value of $66.06 and a signal-adjusted FV of $65.59, implying roughly -32% downside if the model is right. The DCF ($65.26) and EPV floor ($29.03) both sit well below the market, and only the anchored-P/E ($104.67) supports today's tape - and that method essentially extrapolates the current multiple, which is circular. Triangulating, deserved value likely sits in the $65-80 range even after crediting the Strong quality grade and clean earnings; $97 requires the platform-monopoly bull (durable pricing power on data, Adenza cross-sell, sustained double-digit SolutionsBusiness growth) to keep compounding without regulatory or competitive friction. That is a lot of good news already in the price. Earnings quality is high (score 2) so no haircut is warranted there, but leverage from the Adenza deal argues against paying a premium multiple - equity holders are junior to a meaningful debt stack that still needs to be worked down. Net: this is a great business at a full-to-rich price, which is exactly the setup that scores below fair on a mispricing lens.
Verify before trusting this (4)
- Organic growth rate of SolutionsBusiness ex-Adenza in latest 10-Q
- Net debt trajectory and deleveraging pace vs management targets
- Data and listing pricing power - any signs of customer pushback or regulatory scrutiny
- Free cash flow conversion sustainability of the 2025 step-up
The macro tape is mildly supportive: VIX at 14.3 and S&P near highs is exactly the environment where 'boring plumbing' compounders like NDAQ get bid as quality-at-a-price. With beta ~0.97 the market tape lands roughly at index intensity - no amplification either way - so the risk-on regime is a modest tailwind, not a decisive one. The 10y at 4.63% and a 26x market PE are a mild valuation-multiple headwind for a name already trading at a 48% premium to DCF, but nothing in the tape is actively pressing it lower today. The active narrative is the real story: NDAQ is framed as an irreplaceable platform-monopoly with pricing power, AI/compliance optionality, and 'last mile of finance' mythology. Intensity and durability are moderate and cult is low - so no mania, but also no crack. That is a persistent low-grade tailwind: the market keeps paying up for the story, and there is no visible catalyst forcing a re-rate. Momentum confirms the picture without screaming: 16.7% long-term CAGR and +4.2pp over three years is a name in favor, though the recent 11.7% deceleration hints the narrative is maturing rather than accelerating. Net: gentle, durable push higher, not a euphoric one.
Verify before trusting this (4)
- Any regulatory headline on exchange data-fee pricing - the single cleanest way the bull narrative cracks
- Sell-side target revisions or downgrades citing 'priced for perfection' - would flip tone quickly
- A VIX spike or sharp curve move that pressures premium-multiple financials as a group
- Trading-volume or listings data prints that undercut the pricing-power story
Nasdaq is three different AI stories stapled together. The exchange itself is near-insulated in the ABNB sense: matching, clearing and regulated listing status are licence-and-network assets, and more machine intelligence in the market means more messages, more colocation, more data licences — AI arrives as volume, not substitution. The Financial Technology segment is a PAYC-type shield: AxiomSL regulatory reporting and Calypso risk/treasury workflows are legally exhaustive and liability-bearing, so even a technically capable internal LLM build is unattractive because no bank wants to own the regulatory-filing blame; meanwhile AI cuts Nasdaq's own implementation and support cost, the most labour-heavy part of that P&L. Verafin is the genuinely AI-accelerated asset — consortium fraud data across thousands of institutions makes its models better than any single bank's, and AI-enabled fraud and deepfake payment scams expand the addressable problem it is hired to absorb. The exposure that actually matters is the monetized unit in market data and index/analytics: per-user, per-display and per-seat pricing is levered to shrinking human seat counts in finance, and regulatory scrutiny of data fees limits Nasdaq's ability to reprice. Net: the scarce assets get scarcer, the cost base gets cheaper, and the risk is unit-of-charge migration rather than displacement.
None surfaced.
Verify before trusting this (8)
- Regulatory enforcement actions on clients
- Attestation/audit features in product releases
- Client insourcing announcements
- Data revenue growth vs volume growth
- New data/AI licensing agreements
- Regulatory challenges to fee filings
- Verafin cross-institutional detection metrics
- Historical data licensing deals
The world is pushing more compliance, surveillance and risk-reporting obligations onto banks while trading migrates into electronic, data-hungry, index-linked structures — both currents route revenue toward Nasdaq's franchise rather than around it. Passive investing, the bear's supposed threat, is a licensing tailwind. The real world-level constraints are political: regulators periodically challenge market-data and access pricing, and a macro-headwind backdrop (10y ~4.63%, macro flagged as headwind) can keep the IPO window narrow and bank tech budgets tight, which trims the fastest lines rather than reversing them. Net: structurally supported growth, cyclically modulated.
When we made this prediction on Aug 16, 2026, NDAQ was $97.02. We expect it to be $89.50 by Feb 2027, and we consider it great value under $78.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 16, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.